ArticleOncoimmunology
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials.
Jonathan G Pol et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
55 papers cite it
cites it